Artificial intelligence for diagnostics of ALT-positive cancer (AI4CAN)
Duration: 18 months, Funding volume: € 73,590
Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
Duration: 60 months, Funding volume: € 799,350